Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cell Reports|June 22, 2017
Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresRebecca A Dagg, Hilda A Pickett, Axel A Neumann, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Nano Letters|December 15, 2016
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast CancerCharles J Bowerman, James D Byrne, Kevin S Chu, et al.
Molecular Cancer Therapeutics|April 24, 2014
Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancerKshipra M Gharpure, Kevin S Chu, Charles J Bowerman, et al.
BMJ Open|October 15, 2025
Integration of precision medicine into routine cancer care-protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trialsShuang Liang, Skye McKay, Frank Lin, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
Science Translational Medicine|February 6, 2015
Local iontophoretic administration of cytotoxic therapies to solid tumorsJames D Byrne, Mohammad R N Jajja, Adrian T O'Neill, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 10